quantisnow
FeedTopReportsPricing
⌘K
Live feed
15:00:07·45d
INSIDERFiling
Alphatec Holdings Inc. logo

CEO Miles Patrick covered exercise/tax liability with 219,749 shares, decreasing direct ownership by 4% to 5,778,551 units (SEC Form 4)

ATEC· Alphatec Holdings Inc.
Health Care
Original source

Companies

  • ATEC
    Alphatec Holdings Inc.
    Health Care

Recent analyst ratings

  • Oct 28UpdateStifel$20.00
  • Oct 24UpdateAnalyst$19.00
  • Jun 16UpdateLake Street$18.00
  • Aug 1UpdateMorgan Stanley-
  • Jul 8UpdateBarclays$19.00
  • Feb 9UpdateWells Fargo$26.00

Related

  • PR20h
    ATEC to Report First Quarter 2026 Financial Results on May 5, 2026
  • INSIDER14d
    SEC Form 4 filed by Marshall Tyson Eliot
  • INSIDER37d
    CHIEF FINANCIAL OFFICER Koning John Todd sold $986,192 worth of shares (79,789 units at $12.36), decreasing direct ownership by 12% to 600,721 units (SEC Form 4)
  • INSIDER37d
    CHIEF OPERATING OFFICER Lish Scott sold $3,204,580 worth of shares (260,535 units at $12.30), decreasing direct ownership by 24% to 815,704 units (SEC Form 4)
  • INSIDER41d
    EVP, SALES Sponsel David sold $2,046,419 worth of shares (163,452 units at $12.52), decreasing direct ownership by 24% to 504,932 units (SEC Form 4)
  • INSIDER44d
    EVP, PEOPLE & CULTURE Hunsaker Craig E sold $1,441,041 worth of shares (116,367 units at $12.38) and gifted 600 shares, decreasing direct ownership by 6% to 1,725,609 units (SEC Form 4)
  • INSIDER45d
    CHIEF FINANCIAL OFFICER Koning John Todd covered exercise/tax liability with 68,910 shares, decreasing direct ownership by 9% to 680,510 units (SEC Form 4)
  • INSIDER45d
    GENERAL COUNSEL & CORP. SEC. Marshall Tyson Eliot sold $1,109,549 worth of shares (88,835 units at $12.49), decreasing direct ownership by 14% to 559,459 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022